Fig. 4

Meta-analysis of primary outcomes in subgroups based on the quality of included RCTs. In contrast to low biased trials, studies with a high/moderate risk of bias have indicated ivermectin efficacy in the majority of cases. A Mortality, B Progression to severe disease, C Negative RT-PCR